Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
48,324,727
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
298,447
-
Shares change
-
+269,884
-
Total reported value, excl. options
-
$1,190,347
-
Value change
-
+$1,020,510
-
Number of buys
-
9
-
Number of sells
-
-1
-
Price
-
$3.97
Significant Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q3 2023
11 filings reported holding INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value as of Q3 2023.
INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 298,447 shares
of 48,324,727 outstanding shares and own 0.62% of the company stock.
Largest 10 shareholders include HOHIMER WEALTH MANAGEMENT, LLC (186,464 shares), Sigma Planning Corp (48,144 shares), MILLENNIUM MANAGEMENT LLC (24,822 shares), GEODE CAPITAL MANAGEMENT, LLC (23,070 shares), BlackRock Inc. (10,239 shares), WELLS FARGO & COMPANY/MN (2,480 shares), OSAIC HOLDINGS, INC. (2,000 shares), Tower Research Capital LLC (TRC) (1,027 shares), Glassman Wealth Services (200 shares), and JPMORGAN CHASE & CO (1 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.